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The biliary anastomosis remains a common site of postoperative complications in liver transplantation (LT). Biliary complications
have indeed been termed the “Achilles’ heel” of LT, and while their prevention, diagnosis, and treatment have continued to evolve
over the last two decades, various challenges and uncertainties persist. Here we present the case of a 33-year-old man who, 10 years
after undergoing LT for idiopathic recurrent intrahepatic cholestasis, was noted to have developed pruritus and abnormalities
in serum liver biochemistries during routine post-liver transplant follow-up. Abdominal ultrasound revealed a linear, 1.5mm
hyperechoic filling defect in the common bile duct; magnetic resonance cholangiopancreatography demonstrated a curvilinear
filling defect at the level of the choledochocholedochostomy, corresponding to the ultrasound finding, as well as an anastomotic
biliary stricture (ABS). On endoscopic retrograde cholangiography (ERC), a black tubular stricture with overlying sludge was
encountered and extracted from the common bile duct, consistent with a retained 5 Fr pediatric feeding tube originally placed at
the time of LT. The patient experienced symptomatic and biochemical relief and successfully underwent serial ERCs with balloon
dilatation andmaximal biliary stenting forABSmanagement.With this case, we emphasize the importance of ensuring spontaneous
passage or removal of intraductal prostheses placed prophylactically at the time of LT in order tominimize the risk of chronic biliary
inflammation and associated sequelae, including cholangitis and ABS formation. We also provide herein a brief review of the use
of prophylactic internal transanastomotic prostheses, including biliary tubes and stents, during LT.
1. Introduction
The biliary anastomosis, typically constructed via choledo-
chocholedochostomy, remains the most common anatomical
site for postoperative complications in LT. Indeed, biliary
complications have been regarded as the “Achilles’ heel” of
LT and are a source of significant morbidity. We present a
case of late anastomotic biliary stricture (ABS) development
presenting 10 years after LT for idiopathic recurrent intra-
hepatic cholestasis in the setting of an intraductally retained
5 Fr pediatric feeding tube placed prophylactically at the
time of LT and provide a synopsis of the rationale for, use,
and outcomes of prophylactic transanastomotic prostheses,
including biliary tubes and stents, during LT.
2. Case Report
The patient is a 33-year-old man with a history of progressive
idiopathic recurrent intrahepatic cholestasis diagnosed ini-
tially at the age of 15. He was managed with ursodeoxycholic
acid, cholestyramine, rifampin and naloxone but eventually
failed medical therapy as evidence by the development of
cirrhosis complicated by ascites, esophageal variceal hemor-
rhage, pruritus, and progressively rising Model for End-Stage
Liver Disease score.
At the age of 22, the patient underwent deceased-donor
LT.At the time of LT, the patient’s native bile ductwas noted to
be 10mm indiameter, while the donor bile ductwas 2.5mm in
diameter. In order to make the two orifices more congruent,
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Figure 1: Abdominal ultrasound with filling defect in bile duct.
a ductoplasty was performed with part of the recipient bile
duct being oversewn and an end-to-end choledochochole-
dochostomy being created with running circumferential 5-
0 absorbable sutures. The total cold ischemia time was 8
hours, 32 minutes, and the total warm ischemia time was 41
minutes.Therewere no intraoperative complications, and the
patient recovered well following surgery. He was managed on
tacrolimus and did well for a decade. Approximately half-
way through this period, for geographical and insurance
reasons, the patient transferred LT care to our institution. At
his 10 year post-LT appointment, the patient endorsed new-
onset generalized pruritus and was noted to have developed
multiple albeit relatively minor abnormalities in his serum
liver test profile, with an alkaline phosphatase of 121 (normal:
35-115 U/L), aspartate aminotransferase of 53 U/L, alanine
aminotransferase of 68 U/L, and total bilirubin of 1.2mg/dL.
Abdominal ultrasound showed no evidence of intrahep-
atic or extrahepatic biliary ductal dilatation but did note a
linear filling defect within the common bile duct (CBD) as
seen in Figure 1. MRI/MRCP was thus performed, which
was significant for an abrupt change in caliber at the biliary
anastomosis consistent with stricture (ABS), dilatation of the
common hepatic duct (CHD) to 7mm, and a curvilinear
filling defect at the level of the anastomosis (Figure 2). Given
these findings, the patient’s original LT operative report was
retrieved from the performing institution; this revealed that
in addition to the ductoplasty, a 3.5cm segment of 5 Fr
pediatric feeding tube had been placed through the biliary
anastomosis to serve as a temporary internal stent.
Given the patient’s new-onset pruritus, worsening serum
liver tests, and abnormal imaging findings, endoscopic retro-
grade cholangiography (ERC) was performed. This revealed
a small, tortuous native (i.e., recipient) CBD and a short ABS
with proximal CHD dilatation. The ABS was first balloon
dilated to 6mm followed by sweeping of the extrahepatic
duct was performed with a 9mm extraction balloon; this first
yielded biliary sludge, but with additional sweeps, a 3.5 cm
long, black tubular structure with overlying sludge/biofilm
was extracted (Figures 3(a) and 3(b)). This was grasped and
brought out per osusing forceps and appeared to be consistent
with an oxidized pediatric feeding tube (Figure 4). An 8mm
× 4 cm CRE balloon was then used to further dilate the ABS,
and two 10 Fr x 7 cm Cotton-Leung plastic biliary stents were
deployed across it. In doing so, the patient’s serum laboratory
Figure 2: MRI/MRCP showing anastomotic biliary stricture, com-
mon hepatic ductal dilatation, and subtle curvilinear filling defect
within the common hepatic duct.
tests returned to baseline, and his pruritus resolved over the
ensuing weeks. The patient now nears completion of serial
ERCs at threemonth intervals as part of a 1-year longmaximal
stenting protocol in order to achieve durable ABS resolution
[1].
3. Discussion
The biliary anastomosis represents the most common
anatomical site for postoperative complications in LT and is
a cause of significant morbidity. Accordingly, biliary com-
plications have been termed the “Achilles’ heel” of LT [2–
4]. Biliary strictures are among the most frequent major
complications involving the anastomosis and can be classi-
fied as either anastomotic (ABS) or nonanastomotic based
on location, appearance, and suspected etiology [5]. With
respect to the former, a recent meta-analysis of over 14,000
LTs found the incidence of ABS to be approximately 13% [2].
ABSs can develop at any time following LT, but the majority
present within one year of LT (mean 5-8months) [2]. ABSs in
the early postoperative period are usually related to surgical
technique and/or mismatch of recipient and donor bile ducts,
while late-onset ABSs are believed to be secondary to fibrosis
from preceding local ischemia or chronic inflammation-
related injury [5, 6]. Historically, several surgical techniques
have existed for constructing the biliary anastomosis, with
additional measures being employed to deal with significant
size mismatch between the donor and recipient bile ducts,
as in the case of our patient [7, 8]. Early biliary recon-
structions included loop choledochojejunostomy, Roux-en-
Y choledochojejunostomy (RYCJ), and using the gallbladder
as a conduit [7, 8]. In the 1980s, duct-to-duct anastomosis
became the most popular technique. Compared to RYCJ and
similar surgical techniques, the duct-to-duct anastomosis has
the theoretical advantage of no bowel manipulation, less
biliary reflux by virtue of an intact sphincter, potentially
decreased cholangiocarcinoma risk, and easier endoscopic
access (when needed for biliary intervention) [7, 8]. For
a number of years, the duct-to-duct anastomosis was con-
structed over a percutaneous T-tube (irrespective of bile duct
size discrepancy) in an effort to bridge the biliary anastomosis
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Figure 3: (a) ERC showing black pediatric feeding tubewith overlying biofilm protruding from the papilla. (b) ERCwith successful extraction
of black pediatric feeding tube from the papilla.
Figure 4: Extracted pediatric feeding tube.
and thereby decrease the risk of ABS formation [9]. However,
T-tubes have been associated, at least in some studies, with
higher rates of biliary complications, especially leakage from
the T- tube exit site, and over the last couple decades are
thus no longer routinely used in LT at most centers [2, 10].
In cases where there is significant size mismatch between the
donor and recipient bile ducts, additional measures which
have been employed include: partially closing a patulous
recipient CHD or CBD, spatulating the donor duct, everting
the recipient CBD, creating a common orifice between the
cystic and common ducts, side-to-side ductal anastomosis,
or choledochoduodenostomy. These techniques may be per-
formed with or without the use of temporary internal stents.
The use of an internal stent across the biliary anastomosis
theoretically eliminates the possible complications associated
with T-tubes while preserving the integrity of the biliary
anastomosis. Johnson et al. were the first to review the use
of prophylactic internal transanastomotic biliary stenting at
the time of LT [11]. They placed 6Fr double-J ureteral stents
in a transanastomotic, transpapillary fashion and reported a
significantly lower biliary complication rate in patients with
internal stenting compared to those with T-tubes (18% versus
38%) [11]; there was also a trend towards a lower incidence
of ABS development in the internal stent group (7.6% versus
11%) [11].
Multiple studies have since followed with somewhat
conflicting findings and thus a lack of convincingly beneficial
results. For example, Trachart et al. studied the use of 8 Fr x
2 cm internal stents fabricated from a T-tube and reported a
lower rate of ABS compared to the nonstent group (5% versus
15.1%) [12]. Similarly, Jung et al., using 6-8 Fr silastic stents,
reported a statistically significant lower ABS rate in the stent
group compared to the nonstent group (3.23% versus 11.76%)
[13]. In contrast, Mathur et al. found that the use of transanas-
tomotic, transpapillary 5-8Fr silastic pediatric feeding tubes
were associated with higher rates of ABS, although the
difference was not statistically significant [14]. Mathur et al.
concluded that prophylactic internal stenting did not reduce
risk of biliary complications and was instead associated with
a higher adjusted risk for requiring endoscopic interventions
(e.g., ERC) within the first 90 days post-LT [14].
In an effort to minimize the need for endoscopic proce-
dures for stent removal, studies have since been performed
using synthetic bioabsorbable stents [15]. Janousek et al.
investigated the use of transanastomotic bioabsorbable bil-
iary stents, made from polydioxanone monofilaments. None
of the patients in the stent group developed biliary strictures;
however, the sample size was small, and long term follow-
up was not reported [15]. Most recently, the first randomized
control trial assessing the efficacy of prophylactic transanas-
tomotic stenting for duct-to-duct biliary reconstruction in
LT was performed [16]. Santosh Kumar et al. randomized LT
recipients to either receive a transanastomotic, transpapillary
3-5 Fr ureteric stent or no stent; the authors reported a trend
towards higher stricture formation in the stent group com-
pared to the nonstent group (22.6% versus 6.1%), although
this was not statistically significant [15]. Given a significantly
higher risk of bile leak in the stent group, the trial was
terminated early [16].
While the aforementioned studies have varied in the
type and size of stents used, the fashion in which they were
placed, and the duration for which they were left in situ, it
is important to note that they all ensured stent passage or
removal (or bioabsorption). Johnson et al. reported that 43%
of internal stents passed spontaneously, while the remaining
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57% required endoscopic removal [11]. Similarly, Tranchart
et al. reported that 95% of their patients with internal stents
required endoscopic removal, as only 5% of stents were noted
to have passed spontaneously [12]. Therefore, it is imperative
that sight not be lost of these stents, and that appropriate
follow-up (and if needed, removal) be performed, as with
other pancreatobiliary stents.
In our patient, whilemismatch in donor and recipient bile
duct size was a potential risk factor for the development of
ABS, it is likely that the prolonged presence of a foreign object
in the form of a retained transanastomotic pediatric feeding
tube served as a nidus of chronic, low-grade inflammation
and ultimately contributed to the development of the patient’s
late-onset ABS. Therefore, stent removal was recommended,
and in doing so, the patient benefitted from symptomatic,
biochemical, and cholangiographic improvement.
While we await amore definitive verdict on the efficacy of
temporary prophylactic transanastomotic biliary stents in LT,
it is clear that if placed, non-bioabsorbable intraductal stents
should be removed (if spontaneous passage is not observed)
to minimize the risk of developing complications down the
road, including cholangitis and/or ABS formation. Our case
emphasizes the importance of the routine use of imaging
as well as other safeguards following intraductal prosthesis
placement to either document spontaneous stent passage or
identify patients who may require further evaluation and
potentially endoscopic stent removal.
Abbreviations
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ERC: Endoscopic retrograde cholangiography
LT: Liver transplantation.
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